The company has gone from commercilisation in early 2024, to this:
To here......
...from a day or so ago. It doesn't sound like "Cynata's clear priority is to advance its Phase 2 clinical trial for graft-versus-host disease". It didn't get much air play at all, did it?
Cynata's vague priority?
KK has said they have enough cash for all the trials (with the only one being funded by Cynata being the former 'clear priority' of GVHD).
It's looking like a treMENDous mirage. Some bright spark on here called it from the very beginning, didn't they?
Look over there.........I think I see a foot ulcer......?!......and a bandaid......?!
The company has gone from commercilisation in early 2024, to...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.5¢ | 26.0¢ | $22.52K | 86.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 34500 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 8292 | 2 |
View Market Depth
| Last trade - 15.25pm 19/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |